Class II · Moderate risk
Lanreotide Injection
Lack of Assurance of Sterility: Due to an FDA observation at the contract manufacturing site for deficiencies in their visual inspection procedure.
National Drug Code
Is NDC 69097-0870-67 recalled?
Lanreotide Acetate · 1 SYRINGE in 1 CARTON (69097-870-67) / .5 mL in 1 SYRINGE
Yes — this exact package was recalled
2 FDA recalls name the code 69097-0870-67 directly. A recall still applies to particular lot numbers — compare the lot on your package with the FDA notice below, and talk to your pharmacist before stopping a prescribed medication.
2 of these recalls are still ongoing.
- Active ingredient
- lanreotide acetate
- Strength
- LANREOTIDE ACETATE 120 mg/.5mL
- Form
- Injection · Subcutaneous
- Labeler
- Cipla USA Inc.
- Type
- Human Prescription Drug
- Product code
- 69097-0870
Recalls naming this package
Class II · Moderate risk
Lanreotide Injection
Presence of Particulate Matter.
Where to find this code. The NDC is printed on the pharmacy label and on the manufacturer's carton, usually as three groups of digits after “NDC”. The last group is the package size — two bottles of the same medicine can differ only in that group, and a recall may cover one but not the other.
Other recalled products from this labeler
- 69097-0341 Difluprednate 3
- 69097-0410 Cinacalcet 3
- 69097-0411 Cinacalcet 3
- 69097-0412 Cinacalcet 3
- 69097-0142 Albuterol Sulfate 2
- 69097-0537 Testosterone Cypionate 2
Free recall alerts
Know the day your medication is recalled
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.